Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Olli Vapalahti and Anu Kantele.
Olli Vapalahti
Connection Strength
0.868
Anu Kantele
  1. Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays. Viruses. 2021 05 26; 13(6).
    View in: PubMed
    Score: 0.237
  2. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Travel Med Infect Dis. 2021 Jan-Feb; 39:101949.
    View in: PubMed
    Score: 0.230
  3. Characterization of low-density granulocytes in COVID-19. PLoS Pathog. 2021 07; 17(7):e1009721.
    View in: PubMed
    Score: 0.060
  4. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun. 2021 06 28; 12(1):3991.
    View in: PubMed
    Score: 0.060
  5. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2. Viruses. 2021 Jan 20; 13(2).
    View in: PubMed
    Score: 0.058
  6. Effects of Environmental Factors on Severity and Mortality of COVID-19. Front Med (Lausanne). 2020; 7:607786.
    View in: PubMed
    Score: 0.058
  7. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020 11; 30(6):1012-1016.
    View in: PubMed
    Score: 0.056
  8. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19. Cell Rep Med. 2020 08 25; 1(5):100078.
    View in: PubMed
    Score: 0.056
  9. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. 2020 03; 25(11).
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.